An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)
Clinical trial NCT04941768 · COMPLETED
Trial details
- NCT number
- NCT04941768
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-09
- Primary completion
- 2024-08-08
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.